SEC Form 4 · accession 0001181431-15-004872
Sagent Pharmaceuticals, Inc. · SGNT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Albert Patterson
Officer — EVP, Nat. Accts and Corp. Dev.
Period of report
Mar 19, 2015
Accepted (ET)
Mar 19, 2015 · 3:47 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001369786
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 19, 2015 | F | 66 | $27.32 | D | 36,930 | D |
Table II — derivative securities
No Table II lines on this filing.